Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €105.00. The ...
The anti-vaccine movement in the U.S. has gained momentum with President-elect Donald Trump's nomination of Robert F. Kennedy ...
Sanofi (SYN) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ETCompany ParticipantsPaul Hudson - Chief Executive OfficerFrancois-Xavier Roger ...
4d
French drug major Sanofi (SNY) announced Monday that its Sarclisa has obtained first approval in China for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback